|
Blow to GMCH as surgeon resigns
Times of India “Infrastructures like full-time perfusionists, professionals who operate heart and lung machines during surgical procedures, and resident doctors are very necessary, which is lacking in the GMCH,” Soni said. Refuting the allegations of internal … |
Blunder fears as woman, 66, dies – Hong Kong Standard
Blunder fears as woman, 66, diesHong Kong StandardFirst admitted to United Christian on October 25 for acute bronchitis, she was allowed to return home after five days and prescribed a six-day course of the oral steroid, Prednisolone 25 milligram. Duri…
Physical Activity, Sedentary Time Linked to Heart Failure in Men – Monthly Prescribing Reference
|
Physical Activity, Sedentary Time Linked to Heart Failure in Men
Monthly Prescribing Reference (HealthDay News) — For middle-aged men, physical activity and sedentary time are associated with the risk of heart failure, according to a study published in the January issue of Circulation: Heart Failure. Deborah Rohm Young, Ph.D., from Kaiser … |
NIH Study For Secondary-Progressive MS Underway On Experimental Drug … – BioNews Texas
BioNews TexasNIH Study For Secondary-Progressive MS Underway On Experimental Drug …BioNews TexasIn this study, Rituximab be delivered intravenously and directly into the cerebrospinal fluid by lumbar puncture of about 80 people with secondary-progres…
French First Lady to visit India in first post-scandal outing – New Straits Times
|
French First Lady to visit India in first post-scandal outing
New Straits Times She will be shown around the city by French actress Charlotte Valandrey, who is involved in the cause of promoting organ donations and transplants. First Lady denies ‘clarification’ remarks. The trip comes after a spat between Trierweiler and her … |
A Pill 'Melts Away' Common Form Of Leukemia – RedOrbit
|
A Pill ‘Melts Away’ Common Form Of Leukemia
RedOrbit They found that those who received the combination of idelalsib and rituximab went longer without their disease worsening than those who received only rituximab, which has been the standard of care. Six months into the study, cancers in 93 percent of … |
Halozyme Therapeutics recommended for European Commission approval – San Diego Source (subscription)
|
Halozyme Therapeutics recommended for European Commission approval
San Diego Source (subscription) The treatment is Roche’s subcutaneous formulation of MabThera (rituximab) using Halozyme’s recombinant human hyaluronidase (rHuPH20). “This subcutaneous formulation of MabThera, pending approval in the EU, provides a new route of administration … Halozyme Announces Positive Opinion From CHMP For European Approval Of …PR Newswire (press release) |
A pill may replace chemo in treating leukemia – Manoramaonline
A pill may replace chemo in treating leukemiaManoramaonlineA team of researchers from 19 medical centres in five countries have found that use of a combination of two targeted drugs – idelalsib and rituximab – can make the use of debilitating chemother…
European Setback For Novartis Heart Failure Drug – Forbes
Economic Times |
European Setback For Novartis Heart Failure Drug
Forbes The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended against giving market approval to serelaxin (Reasanz) for the treatment of acute heart failure. The recommendation is based largely on the … Novartis still sees heart failure blockbuster after EU blowEconomic Times UPDATE 2-Novartis still sees heart failure blockbuster after EU blowReuters Novartis to request re-examination of serelaxin (RLX030) in acute heart …FiercePharma Reuters India –Businessweek all 44 news articles » |
Novartis to request re-examination of serelaxin (RLX030) in acute heart … – FiercePharma
Novartis to request re-examination of serelaxin (RLX030) in acute heart …FiercePharmaBasel, January 24, 2014 – Novartis announced today it will shortly submit a revised filing package, including new data analyses, for re-examination for conditional a…